Corrigendum to “Aberrant CDK4/6-driven cell-cycle reentry drives neuronal loss and defines a therapeutic target in C9orf72 ALS/FTD” [iScience 29 (2026) 114596]
- DOI
- 10.1016/j.isci.2026.117845
- Published
- 2026-10
- Container
- iScience
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2026.117845,
title = {Corrigendum to “Aberrant CDK4/6-driven cell-cycle reentry drives neuronal loss and defines a therapeutic target in C9orf72 ALS/FTD” [iScience 29 (2026) 114596]},
author = {Sk Imran Ali and Ling Lian and Hayley Robinson and Noah Daniels and G. Aleph Prieto and Gunnar H.D. Poplawski and Rodrigo Lopez-Gonzalez},
year = {2026},
journal = {iScience},
doi = {10.1016/j.isci.2026.117845},
url = {https://doi.org/10.1016/j.isci.2026.117845}
}RIS
TY - JOUR TI - Corrigendum to “Aberrant CDK4/6-driven cell-cycle reentry drives neuronal loss and defines a therapeutic target in C9orf72 ALS/FTD” [iScience 29 (2026) 114596] AU - Sk Imran Ali AU - Ling Lian AU - Hayley Robinson AU - Noah Daniels AU - G. Aleph Prieto AU - Gunnar H.D. Poplawski AU - Rodrigo Lopez-Gonzalez PY - 2026 JO - iScience DO - 10.1016/j.isci.2026.117845 UR - https://doi.org/10.1016/j.isci.2026.117845 ER -
APA
Ali, S. I., Lian, L., Robinson, H., Daniels, N., Prieto, G. A., Poplawski, G. H., & Lopez-Gonzalez, R. (2026). Corrigendum to “Aberrant CDK4/6-driven cell-cycle reentry drives neuronal loss and defines a therapeutic target in C9orf72 ALS/FTD” [iScience 29 (2026) 114596]. iScience. https://doi.org/10.1016/j.isci.2026.117845
Source records
- crossref · retrieved 2026-11-05T06:58:28.982Z